Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
PAX3 haploinsufficiency is known to cause Waardenburg syndrome.
|
25928000 |
2015 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
PAX3 gene structure and mutations: close analogies between Waardenburg syndrome and the Splotch mouse.
|
7981674 |
1994 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
A novel mutation of PAX3 in a Chinese family with Waardenburg syndrome.
|
16971891 |
2006 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
A novel PAX3 mutation in a Korean patient with Waardenburg syndrome type 1 and unilateral branch retinal vein and artery occlusion: a case report.
|
30314436 |
2018 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome.
|
1347149 |
1992 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Based on the molecular defect of Splotch, an established mouse model for NTD, and on the clinical association between NTD and Waardenburg syndrome (WS), mutations in the PAX3 gene can be expected to act as factors predisposing to human NTD.
|
7897628 |
1995 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Based on the molecular defect of Splotch, an established mouse model for NTD, and on the clinical association between NTD and Waardenburg syndrome (WS), mutations in the PAX3 gene can be expected to act as factors predisposing to human NTD.
|
7897628 |
1995 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Correlation between Waardenburg syndrome phenotype and genotype in a population of individuals with identified PAX3 mutations.
|
9654197 |
1998 |
Waardenburg Syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Correlation between Waardenburg syndrome phenotype and genotype in a population of individuals with identified PAX3 mutations.
|
9654197 |
1998 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Dense mapping using interval markers narrowed the locus down to a 670-kbp region, containing four genes including Pax3, a gene known to be implicated in the types I and III Waardenburg syndrome.
|
28043919 |
2017 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Dense mapping using interval markers narrowed the locus down to a 670-kbp region, containing four genes including Pax3, a gene known to be implicated in the types I and III Waardenburg syndrome.
|
28043919 |
2017 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Effects of Pax3 modifier genes on craniofacial morphology, pigmentation, and viability: a murine model of Waardenburg syndrome variation.
|
8786127 |
1996 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Epistatic relationship between Waardenburg syndrome genes MITF and PAX3.
|
9500554 |
1998 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Evaluation of heterogeneity in location scores obtained by multilocus analysis indicated that WS is linked to PAX3 in 60% of all WS families and in 100% of WS1 families.None of the WS2 families were linked.
|
7942851 |
1994 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Genes responsible for syndromic forms of hearing loss include the COL4A5 gene in Alport syndrome and the PAX3 and MITF genes in Waardenburg syndrome.
|
8630497 |
1996 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Genomic DNA from probands of various Waardenburg syndrome (WS) families were PCR-amplified using primers flanking the 8 exons of PAX3.
|
9017978 |
1997 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Germline mutations of the murine Pax3 and human PAX3 genes cause deficiencies in these developmental lineages and result in the Splotch phenotype and Waardenburg syndrome, respectively.
|
29730428 |
2018 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Here we describe a further three PAX3 mutations which cause WS; one alters the octapeptide motif plus the presumed homeodomain; a second alters all three elements and the third alters the paired box alone.
|
8490648 |
1993 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Here we show that some families with WS have mutations in the human homologue of Pax-3.
|
1347148 |
1992 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Here, we demonstrate that PAX3, which is often mutated in Waardenburg syndrome, is required for normal enteric ganglia formation.
|
11032856 |
2000 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Homozygous and heterozygous inheritance of PAX3 mutations causes different types of Waardenburg syndrome.
|
12949970 |
2003 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Identification of a Novel De Novo Variant in the PAX3 Gene in Waardenburg Syndrome by Diagnostic Exome Sequencing: The First Molecular Diagnosis in Korea.
|
25932447 |
2015 |
Waardenburg Syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Identification of a novel nonsense mutation on the Pax3 gene in ENU-derived white belly spotting mice and its genetic interaction with c-Kit.
|
20095975 |
2010 |
Waardenburg Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In the human paired box-containing (PAX) gene family, only two members, PAX-3 and PAX-6, which are associated with Waardenburg's syndrome and aniridia, respectively have been mapped to human chromosomes.
|
7981748 |
1993 |